RAF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.92912352758867E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.36952687973735E-13 |
Normal-vs-Stage2 |
1.03919994831614E-09 |
Normal-vs-Stage3 |
4.12059997234593E-09 |
Normal-vs-Stage4 |
2.04649630575204E-11 |
Stage1-vs-Stage2 |
3.476000E-01 |
Stage1-vs-Stage3 |
8.410000E-02 |
Stage1-vs-Stage4 |
2.663900E-02 |
Stage2-vs-Stage3 |
6.019800E-01 |
Stage2-vs-Stage4 |
9.459800E-02 |
Stage3-vs-Stage4 |
3.234600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.37698749572246E-13 |
Normal-vs-AfricanAmerican |
6.31872332235162E-12 |
Normal-vs-Asian |
3.960100E-02 |
Caucasian-vs-AfricanAmerican |
7.760400E-01 |
Caucasian-vs-Asian |
7.193400E-01 |
AfricanAmerican-vs-Asian |
7.629200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.68720593052285E-12 |
Normal-vs-Female |
8.71060001905732E-09 |
Male-vs-Female |
1.416240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
8.10684852581289E-12 |
Normal-vs-Extreme_Weight |
6.88227252965135E-13 |
Normal-vs-Obese |
5.38089572899025E-11 |
Normal-vs-Extreme_Obese |
7.216400E-03 |
Normal_Weight-vs-Extreme_Weight |
5.023200E-01 |
Normal_Weight-vs-Obese |
3.026400E-01 |
Normal_Weight-vs-Extreme_Obese |
4.245800E-01 |
Extreme_Weight-vs-Obese |
6.763800E-01 |
Extreme_Weight-vs-Extreme_Obese |
6.820000E-01 |
Obese-vs-Extreme_Obese |
8.378000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.203990E-03 |
Normal-vs-Age(41-60Yrs) |
1.85484960724125E-12 |
Normal-vs-Age(61-80Yrs) |
9.02611319020252E-14 |
Normal-vs-Age(81-100Yrs) |
3.50510000024506E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.006000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.353000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.347400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.438600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.723800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.466200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.59659951926017E-10 |
Normal-VS-Type2 PRCC |
<1E-12 |
Normal-VS-KIRP CIMP |
3.4411000005008E-07 |
Normal-VS-Unclassified PRCC |
7.12990000040215E-07 |
Type1 PRCC-VS-Type2 PRCC |
1.90840000025005E-07 |
Type1 PRCC-VS-KIRP CIMP |
2.688800E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.429200E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.342200E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.049600E-02 |
KIRP CIMP-VS-Unclassified PRCC |
7.447800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.02917674382752E-13 |
Normal-vs-N1 |
9.23816578790593E-13 |
Normal-vs-N2 |
8.77209999972095E-07 |
N0-vs-N1 |
5.514200E-01 |
N0-vs-N2 |
2.907200E-01 |
N1-vs-N2 |
3.773800E-01 |
|
|